Media OutReach
LiveSpo Pharma – Vietnamese pioneer in spore probiotics with international clinical publications, welcomes former BioGaia AB CEO to its Board
The global probiotics market is witnessing exponential growth, projected to reach nearly USD 375 billion by 2034, according to a report by Towards Healthcare (1). Beyond digestive health, probiotics are expanding into respiratory, immune and other new research directions. This presents major opportunities for enterprises with strong scientific capacity and the ability to translate research into community solutions. LiveSpo Pharma, a biotechnology company with the mission ‘A Future Without Antibiotics’,’ has emerged as Vietnam’s representative on the global probiotics map.
In August 2025, researchers at the Spobiotic Research Center (ANABIO R&D) and LiveSpo Pharma, in collaboration with Vietnamese pediatricians, published two important clinical trials in the Nature Portfolio. These pioneering studies evaluated Bacillus spore probiotics in nasal spray form (LiveSpo NAVAX) and high-dose oral form (LiveSpo DIA30), demonstrating effectiveness in shortening treatment time, reducing antibiotic demand, and restoring microbial balance in the respiratory and digestive tracts of children.
Speaking about LiveSpo NAVAX, the nasal spray probiotic, Isabelle Ducellier, newly appointed Board Member of LiveSpo Pharma, said: “There are many nasal sprays available on the market, but none that contain probiotics. When reviewing the scientific data developed by LiveSpo’s R&D team, I was truly impressed by the robust, systematic evidence of effectiveness. The studies were conducted rigorously, and the results highlighted the potential to improve community health, worthy of recognition by prestigious scientific journals.”
This is precisely why LiveSpo Pharma has attracted Ms. Isabelle Ducellier, former CEO of BioGaia AB (Sweden), a global probiotics brand, to its Board of Directors. With over 25 years of experience at leading European and global corporations, Ms. Ducellier successfully expanded BioGaia’s presence to more than 100 countries.
LiveSpo was founded by Dr. Nguyen Hoa Anh, who earned a Ph.D. in Life Sciences from Tohoku University (Japan), with the mission of developing water-based spore probiotic technology. After more than a decade, the company has created spore probiotic technology featuring six breakthroughs: liquid form, multi-strain, high concentration, heat resistant, acid resistant and long shelf life.
Remarkably, LiveSpo has developed a nationwide distribution network, present in leading pharmacy chains, traditional drugstores, and mother & baby retail systems, while its e-commerce channels directly reach more than 1 million users.
A key differentiator of LiveSpo is its scientific transparency. All clinical trials are registered on the U.S. National Institutes of Health (NIH) ClinicalTrials.gov system. To date, LiveSpo Pharma has had six studies published in the Nature Portfolio—clear evidence of the rigor, transparency, and scientific value of its products. Nature Portfolio, under Springer Nature, is one of the world’s leading scientific journal systems, renowned for rigorous peer review standards and significant global impact. Within the system, Communications Medicine focuses on biomedical and clinical research, while Scientific Reports is an open-access journal with large-scale publications, ranked among the most-cited worldwide (with over 830,000 citations annually).
The most recent study, published in Communications Medicine – Nature (Impact Factor 2024: ~6.3; SCImago Q1), is titled ‘Bacillus spore-based nasal spray probiotics in the treatment of pneumonia in children with RSV and bacterial co-infection: a randomized clinical trial’ (Le T.H. et al., 2025). The trial demonstrated that LiveSpo NAVAX shortened treatment duration by an average of one day, reduced antibiotic use by nearly 15%, and improved the nasal microbiota by reducing pathogens such as Streptococcus pneumoniae and Haemophilus influenzae. Within one month of publication (07/08/2025), the article attracted nearly 1,800 views and reached an Altmetric score of 12—indicating notable engagement for a clinical research article.
Another study published in Scientific Reports – Nature reported that the use of LiveSpo DIA30 significantly shortened treatment duration and reduced antibiotic usage by 25 per cent. This paper by Dang T.H. et al. (2025), titled ‘High-dose multi-strain Bacillus probiotics enhance treatment and reduce antibiotic usage in children with persistent diarrhea through immune and microbiota modulation’.
The strength of these publications lies not only in their findings but also in their international resonance. They align with major global research directions, such as RSV vaccine study at Yale university (Du et al., 2025; Nature Medicine), the nasal influenza vaccine study at the Icahn School of Medicine (Vasilev et al., 2025; NPJ Vaccines) and gut microbiota studies on diarrhea (Vasilev et al., 2025; Yang et al., 2025; Nature Communications). With strong reader engagement and alignment with leading research directions in the Nature Portfolio, these results highlight the potential of spore-based probiotics to improve child health, reduce disease burden, and curb antibiotic resistance—particularly in resource-limited countries.
With a solid scientific foundation, strategic development roadmap, and partnerships with seasoned international experts, LiveSpo is gaining vital momentum for breakthrough growth. The addition of Ms. Isabelle Ducellier, former CEO of BioGaia AB, to the Board of Directors not only brings global expertise and perspective but also opens opportunities to connect with international networks, markets, and standards. Especially, the recent clinical publications in the Nature Portfolio further reinforce LiveSpo’s scientific credibility, laying the groundwork for delivering safe, effective Vietnamese healthcare solutions to both domestic and global communities, and highlighting Vietnam’s growing contributions to global probiotic research.
(1) : https://www.towardshealthcare.com/insights/probiotics-market-sizing
REFERENCES
1. Dang, H.T., Phung, T.T.B., Tran, D.M. et al. High-dose multi-strain Bacillus probiotics enhance treatment and reduce antibiotic usage in children with persistent diarrhea through immune and microbiota modulation. Sci Rep 15, 30231 (2025). https://doi.org/10.1038/s41598-025-15199-y
2. Thi Le, H., Thi Bich Phung, T., Thi Bui, H. et al. Nasal-spraying Bacillus spore probiotics for pneumonia in children with respiratory syncytial virus and bacterial co-infections: a randomized clinical trial. Commun Med 5, 336 (2025). https://doi.org/10.1038/s43856-025-01029-9
Hashtag: #LiveSpo
https://livespo.comThe issuer is solely responsible for the content of this announcement.
Media OutReach
Luxury Hair Clinic Sheer Reprime Marks 8th Anniversary with a Flagship Expansion into Hong Kong’s Prestigious Wellington Street
Luxury hair and scalp rejuvenation pioneer Sheer Reprime invests nearly HK$10 million to deploy next-generation, FDA and CE-certified hair restoration and scalp rejuvenation technologies.
HONG KONG SAR – Media OutReach Newswire – 8 June 2026 – Celebrating eight years of clinical excellence, premier hair and scalp rejuvenation brand Sheer Reprime today announced the grand opening of its ultra-luxury flagship center on Wellington Street, Central. Representing a strategic investment of nearly HKD10 million, the expansive facility positions Sheer Reprime at the epicenter of Hong Kong’s elite financial and cultural district. This expansion marks a new era of medical-grade, advanced hair restoration and scalp rejuvenation.
Located at 50 Wellington Street, adjacent to the iconic Yung Kee restaurant, the near-full-floor flagship features private treatment suites engineered for maximum comfort and discretion. The venue is optimized for busy and successful individuals, stars and celebrities seeking world-class clinical trichology with exceptional hospitality.
Bridging Follicle Biology and Biophotonics
Sheer Reprime’s expansion directly addresses a surging global market demand for scientifically backed hair-loss solutions, particularly as stress and lifestyle factors accelerate the onset of premature thinning among younger demographics.
“Our expansion into the heart of Central marks a watershed moment for Sheer Reprime,” said a Brand Spokesperson. “The modern consumer demands rigorous, evidence-based hair and scalp treatments. Sheer Reprime is built at the intersection of Follicle Biology and Biophotonics. Our multi-million-dollar investment into an advanced clinical instrumentation allows us to optimize the scalp microenvironment at a cellular level, far surpassing the limitations of older generation treatments.”
Internal clinical metrics validate the brand’s scientific approach. In a recent study tracking 100 urban professionals over a 12-week regimen of Sheer Reprime’s laser hair rejuvenation therapy, participants demonstrated an average increase of 22% in hair shaft thickness and an 18% increase in active follicular density.
Departing from standard industry practices focused merely on surface-level scalp cleansing, Sheer Reprime introduces its proprietary Connotation Therapy. This multi-modality framework combines technologies which have received FDA, Medical CE, and EU MDR (Medical Device Regulation) certifications. Amongst them SLD LLLT hair loss treatment, which delivers biophotonic laser energy 3–5mm beneath the scalp surface to revive the follicular base. Winback Tecar Therapy and 500kHZ cellular radio frequency, which utilizes deep thermal energy to enhance localized microcirculation across the head, neck, and shoulders, maximizing nutrient and oxygen delivery to the hair bulb while flushing out metabolic waste and DHT (dihydrotestosterone).
The launch of Sheer Reprime’s Wellington Street flagship redefines the luxury trichology landscape in Hong Kong, merging clinically proven regenerative technologies with an unparalleled bespoke experience.
Hashtag: #sheerreprime #煥光活髮
The issuer is solely responsible for the content of this announcement.
About Sheer Reprime
Sheer Reprime is a premier scientific hair and scalp rejuvenation brand. By fusing Follicle Biology with Biophotonics, the brand transcends the boundaries of traditional hair care. Operating its multi-million-dollar flagship in Central, Sheer Reprime deploys FDA and CE-certified medical-grade technologies to lead the global industry into the era of cellular hair restoration. For more information, visit: 
http://www.reprime.hk
Media OutReach
Trransfer Technologies And LINE GO Partner To Expand Enterprise Ground Transportation Across Taiwan And Global Markets
Partnership combines LINE GO’s MaaS ecosystem platform with Trransfer Technologies’ global B2B ground transportation platform to serve Taiwan’s growing outbound business travel demand
SINGAPORE – Media OutReach Newswire – 8 June 2026 – Trransfer Technologies, a global B2B ground transportation platform serving corporate travel managers, private aviation firms, banks, luxury concierge services and enterprise customers to fulfill across more than 80 destinations worldwide, announced the official launch of its strategic partnership with LINE GO, Taiwan’s premier MaaS (Mobility as a Service) ecosystem platform. Officially commencing today, the partnership follows a successful one-month operational pilot since May 11, 2026, and is designed to unlock new enterprise demand in Taiwan while creating a scalable outbound travel solution for Taiwanese companies, multinational corporations and business travelers.
Taiwan’s outbound travel market reached 18.94 million departures in 2025, a 12.43 percent increase from 2024 and a new historical high. This upward trajectory underscores a compelling opportunity for enterprise-focused mobility providers to capture demand from corporations and business travelers who require seamless, reliable ground transportation solutions across global destinations.
A Partnership Built on Complementary Strengths
Trransfer Technologies will bring international corporate and enterprise travel demand into Taiwan, with LINE GO providing local fulfillment through its established mobility network, operational capabilities and deep integration within the LINE ecosystem. LINE GO’s MaaS platform aggregates seven mobility services including taxi-hailing, car rentals, airport shuttles, designated driver services, scooter sharing, private car charters and an EV charging network, giving enterprise clients a comprehensive local mobility experience upon arrival in Taiwan.
Looking ahead, both companies will extend their collaboration to serve the outbound travel needs of Taiwan-based enterprises, leveraging Trransfer Technologies’ global destination network across more than 80 destinations worldwide. This positions both companies to become the preferred mobility partner for Taiwanese businesses and multinationals requiring end-to-end ground transportation coordination across borders.
Targeting Taiwan’s Enterprise Traveler Segment
The partnership specifically targets multinational corporations, corporate travel managers, enterprise clients and high-frequency business travelers. As Taiwan’s outbound travel continues its upward trajectory, enterprises increasingly need partners who understand both local logistics and the complexity of global coordination.
“This partnership creates immediate strategic value for both companies. LINE GO brings market-leading mobility technology and operational insights, while Trransfer Technologies contributes the global platform, enterprise workflows and international fulfillment network. Together, we are building a scalable outbound mobility solution for Taiwanese enterprises traveling globally.”
Michael Chiay, Chief Executive Officer, Trransfer Technologies
“This collaboration marks a transformative milestone in LINE GO’s journey. We are proud to offer our partners a one-stop solution that delivers on our promise to make every journey smarter, safer, and more efficient.”
Isaac Lin, Managing Director, LINE GO
Hashtag: #TrransferTechnologies #MaaS #BusinessTravel #CorporateTravel #TravelTech #GlobalMobility #TrransferTechnologies #LineGo #EnterpriseTravel #SmartMobility #concierge
The issuer is solely responsible for the content of this announcement.
About Trransfer Technologies
Trransfer Technologies is a global B2B ground transportation platform connecting corporate travel managers, private aviation firms, banks, luxury concierge services and enterprise customers with local ground transportation operators to fulfill across more than 80 destinations worldwide. The company provides a unified platform designed to simplify business travel mobility, improve supplier coordination and support seamless ground transportation fulfillment across markets.
For more information, please visit www.trransfer.com.
About LINE GO
LINE GO is Taiwan’s premier MaaS platform offering taxi-hailing, car rentals, airport shuttles, designated driver services, scooter sharing, private car charters and an EV charging network, all within the LINE ecosystem. In 2025, LINE GO achieved dual ISO 27001 and ISO 27701 certifications, underscoring its commitment to world-class information security and data privacy.
Media OutReach
Sun Group debuts at SITF 2026 with exclusive Phu Quoc flight deals and a fresh vision for Vietnam tourism
A special highlight is Sun Group’s unveiling of its new development vision for Phu Quoc in the lead‑up to APEC 2027, presented directly to Korean partners and visitors.
From the first day of the fair, Sun Group’s booth has welcomed a steady stream of visitors. Throughout the four-day event, the booth has organized B2B and B2C networking activities, customer consultations, and introductions to tourism, resort, and aviation products. Interactive programs, including mini-games, souvenir giveaways, and tailored offers for the Korean market, have kept the atmosphere lively for hours, with a continuous flow of engaged visitors.
During SITF (June 4–7), travelers have the opportunity to receive a 20% discount on the base fare when booking Sun PhuQuoc Airways tickets via the airline’s website or app. The offer applies to the Korean market for one‑way or round‑trip journeys from Korea to Phu Quoc. Limited to 200 Economy Class discount codes, it is valid for flights from June 15 to October 24, 2026 (excluding peak periods as defined by the airline).
Visitors also have the chance to win attractive prizes through booth activities, including free round‑trip air tickets on the Seoul–Phu Quoc route (ICN–PQC) and resort vouchers at hotels within Sun Group’s ecosystem.
By combining destination promotion with airline incentives, Sun Group aims to further encourage South Korean tourists to choose Vietnam for their upcoming holidays, especially Phu Quoc, which is entering a new era of large‑scale investments in projects, products, and experiences all aimed at APEC 2027.
Hashtag: #SunGroup
The issuer is solely responsible for the content of this announcement.
About Sun Group
Vietnam’s leading private economic group, Sun Group operates an integrated ecosystem spanning tourism, entertainment, hospitality, real estate, infrastructure, and aviation. Guided by the mission “Enhancing the beauty of the lands,” the Group shapes iconic destinations nationwide through its Sun World entertainment brand. In the aviation sector, Sun Group develops a hub-and-spoke model anchored by Phu Quoc, driven by strategic airport investments and Sun PhuQuoc Airways.
-
Feature/OPED6 years agoDavos was Different this year
-
Travel/Tourism10 years ago
Lagos Seals Western Lodge Hotel In Ikorodu
-
Showbiz3 years agoEstranged Lover Releases Videos of Empress Njamah Bathing
-
Banking8 years agoSort Codes of GTBank Branches in Nigeria
-
Economy3 years agoSubsidy Removal: CNG at N130 Per Litre Cheaper Than Petrol—IPMAN
-
Banking3 years agoSort Codes of UBA Branches in Nigeria
-
Banking3 years agoFirst Bank Announces Planned Downtime
-
Sports3 years agoHighest Paid Nigerian Footballer – How Much Do Nigerian Footballers Earn